Compound, endoplasmic reticulum stress inhibitor, pharmaceutical product, ophthalmic agent, eye drops, composition, and method for producing compound
US-2026070921-A1 · Mar 12, 2026 · US
The Doshisha was listed as an assignee on 4 patent publications in 2026.
| Metric | Value |
|---|---|
| Company | The Doshisha |
| Year | 2026 |
| Patents | 4 |
Representative publications for The Doshisha in 2026.
US-2026070921-A1 · Mar 12, 2026 · US
US-2026074205-A1 · Mar 12, 2026 · US
US-2026035804-A1 · Feb 5, 2026 · US
US-2026035826-A1 · Feb 5, 2026 · US
Most common classification codes for The Doshisha in 2026.
| CPC | Patents |
|---|---|
| C01B32/935 | 2 |
| C01B32/942 | 2 |
| C10H21/10 | 2 |
| C25B1/14 | 2 |
| C25B1/18 | 2 |
Navigate to parent entity pages.